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Edited by Francesc PosasAbstract Amino acid-starved yeast activates the eIF2a kinase
Gcn2p to suppress general translation and to selectively dere-
press the transcription factor Gcn4p, which induces various bio-
synthetic genes to elicit general amino acid control (GAAC).
Well-fed yeast activates the target of rapamycin (TOR) to stim-
ulate translation via the eIF4F complex. A crosstalk was demon-
strated between the pathways for GAAC and TOR signaling: the
TOR-speciﬁc inhibitor rapamycin activates Gcn2p. Here we
demonstrate that, upon TOR-inactivation, the putative TOR-
regulated eIF4E-associated protein Eap1p likely functions down-
stream of Gcn2p to attenuate GCN4 translation via a mechanism
independent of eIF4E-binding, thereby constituting another
interface between the two pathways.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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When the budding yeast Saccharomyces cerevisiae starves
for a certain amino acid, uncharged tRNA for that amino
acid accumulates and activates the sole eIF2a kinase Gcn2p
[1,2]. The Gcn2p phosphorylates eIF2a at Ser-51 to convert
it from the substrate to an inhibitor of its guanine nucleotide
exchanger eIF2B. Consequently, the ternary complex com-
posed of eIF2, GTP and methionyl-tRNA is declined to in-
duce general suppression of translation initiation. However,
the translation of GCN4 mRNA is selectively derepressed
via a mechanism dependent on the four upstream open read-
ing frames (uORFs) in its 5 0-leader region, which usually
function as cis-elements to prevent translation of GCN4
ORF [1]. The transcription factor Gcn4p activates genesAbbreviations: eIF, eukaryotic initiation factor; TOR, target of rapa-
mycin; ORF, open reading frame; GAAC, general amino acid control;
4E-BP, eIF4E-binding protein; GST, glutathione-S-transferase; 3AT,
3-aminotriazole; eIF2a[pS51], eIF2a phosphorylated at Ser-51; SC-
Ura, synthetic complete medium lacking uracil; SC-Ura-His, synthetic
complete medium lacking uracil and histidine
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doi:10.1016/j.febslet.2005.03.043for amino acid biosynthesis, including not only those for
the starved amino acid but also those for other, non-starved
ones [2]. Hence the response was termed general amino acid
control (GAAC) and has been extensively investigated.
Translation regulation via phosphorylation of eIF2a repre-
sents the most fundamental mechanism conserved through-
out the eukaryotes [3].
When grown in suﬃcient nutrient levels, the cells activate the
target of rapamycin (TOR) signaling pathway to promote for-
mation of the initiation complex eIF4F, which is composed of
eIF4A, 4E and 4G. Translation initiation is enhanced through
assembly of the eIF4F complex on the 5 0-cap structure of the
mRNA [4,5]. In yeast, the TOR signaling pathway was demon-
strated to stabilize eIF4G, the scaﬀold of eIF4F [6]. In mam-
mals, the TOR signaling causes the phosphorylation of
eIF4E-binding proteins (4E-BPs), which compete with eIF4G
for binding eIF4E to block the assembly of eIF4F. Since the
phosphorylation makes 4E-BPs incapable of binding to eIF4E,
it facilitates the assembly of eIF4F to stimulate translation ini-
tiation. The budding yeast has an eIF4E-associated protein
termed Eap1p [7]. It has been assumed to be a functional
homolog of 4E-BPs, because it shares the 4E-binding motif
with 4E-BPs to bind eIF4E both in vitro and in vivo and be-
cause its removal confers mild resistance to rapamycin, indic-
ative of its involvement in TOR signaling [7]. However, how
Eap1p functions in translation regulation remains largely
elusive.
The pathways for GAAC and TOR signaling should be
reciprocally regulated to coordinate cellular responses to
nutritional stress. Indeed, we and others recently demon-
strated that rapamycin derepresses translation of GCN4
mRNA [8–10]. While this derepression is induced by the acti-
vation of Gcn2p, it is not accompanied by an increment in
uncharged tRNAs but by dephosphorylation of Gcn2p at
Ser-577 [9,10]. The dephosphorylation has been shown to in-
crease the aﬃnity of Gcn2p to uncharged tRNAs, thereby
leading to its activation without increment in uncharged
tRNAs [9,10]. It thus seems that TOR signaling pathway
crosstalks with GAAC pathway to prevent inactivation of
eIF2.
In this study, we examined potential involvement of Eap1p
in the crosstalk between the two pathways. The results indicate
that, upon TOR-inactivation, Eap1p attenuates the translation
of GCN4 mRNA via a novel mechanism independent of
eIF4E-binding.blished by Elsevier B.V. All rights reserved.
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2.1. Yeast strains
The strains used were W303H (MATa ade2-1 trp1-1 leu2-3 ura3-1
can1-100), WH2 (MATa ade2-1 trp1-1 leu2-3 ura3-1 can1-100
gcn2D::KanMX), WH4 (MATa ade2-1 trp1-1 leu2-3 ura3-1 can1-100
eap1D::KanMX), WH9 (MATa ade2-1 trp1-1 leu2-3 ura3-1 can1-100
gcn2-S577A), WH24 (MATa ade2-1 trp1-1 leu2-3 ura3-1 can1-100
gcn2D eap1D::KanMX), WH41 (MATa ade2-1 trp1-1 leu2-3 ura3-1
can1-100 eap1-Y109A), WH42 (MATa ade2-1 trp1-1 leu2-3 ura3-1
can1-100 eap1-Y109A/L114A) and WH94 (MATa ade2-1 trp1-1 leu2-
3 ura3-1 can1-100 gcn2-S577A eap1D::KanMX). All of these strains
were generated by the standard PCR-mediated gene disruption using
the KanMX cassette or by the pop-in–pop-out replacement technique.
2.2. Reporter assay for GCN4 translation
The b-galactosidase assay was performed as previously described
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Fig. 1. Eﬀects of EAP1 deletion on translational derepression of
GCN4. (A) The W303H (EAP1, circle) and WH4 (eap1D, triangle) cells
bearing the GCN4-lacZ reporter plasmid p180 were grown at 30 C to
logarithmic phase in SC-Ura, shifted to SC-Ura containing 200 ng/ml
rapamycin and assayed for b-galactosidase activity at the time points
indicated. (B) Translational depression of GCN4 was measured under
various concentrations of rapamycin for 2 h in W303H (circle) and
WH4 (triangle) cells. (C) The W303H (circle) and WH4 (triangle) cells
bearing p180 were grown as in (A) and shifted to SC-Ura-His
containing 20 mM 3AT and assayed for b-galactosidase activity at the
time points indicated.2.3. Immunoblot analysis
The immunoblot assay using an anti-phospho-eIF2a or anti-T7 anti-
body was conducted as previously described [10–12].
2.4. Far-western blot assay for eIF4E-binding
The yeast proteins separated by SDS–polyacrylamide gel electropho-
resis were transferred to nitrocellulose membrane, which was subse-
quently probed with the puriﬁed glutathione-S-transferase (GST)–
eIF4E. The bound probe was detected using an anti-GST antibody
as described [11,12].3. Results
3.1. Deletion of EAP1 enhances rapamycin-induced GCN4
translation
To examine the eﬀect of Eap1p on rapamycin-induced
GCN4 translation, we generated a strain deleted for the entire
ORF of EAP1 by PCR-mediated one-step gene disruption
using the KanMX cassette. The eap1D cells were transformed
with the p180 reporter plasmid. It bears the 5 0-leader region
of GCN4 mRNA followed by lacZ ORF and has been used
to report the translational derepression [1]. Conﬁrming no sig-
niﬁcant diﬀerence in growth between the parental and eap1D
cells, we measured the b-galactosidase activity driven by the
p180 reporter plasmid. As shown in Fig. 1A, rapamycin in-
duced the activity more eﬃciently in eap1D cells than in the
parental cells. We carried out the experiment with increasing
doses of rapamycin, and found that 200 ng/ml of rapamycin
enhanced b-galactosidase more prominently (Fig. 1B). We also
conﬁrmed that the enhancement was observed in other strain
backgrounds (data not shown).
In addition to the association with eIF4E, Eap1p has been
implicated in spindle pole body duplication and segregation
of chromosomes [13]. It is formally possible that the deletion
of EAP1 somehow aﬀects the copy number of the centromeric
p180 reporter plasmid to result in an increased dosage of lacZ
mRNA. To rule out this possibility, we performed quantitative
PCR to conﬁrm that both p180 plasmid and lacZ mRNA
showed no diﬀerence in their abundance between the EAP1
and eap1D cells (data not shown). It thus seems that the dele-
tion of EAP1 enhances the rapamycin-induced translation of
GCN4 mRNA.
3.2. Overexpression of EAP1 suppresses rapamycin-induced
GCN4 translation
From the ﬁndings described above, we expected that rapa-
mycin-induced GCN4 translation can be suppressed by
increasing the dosage of EAP1. We constructed a plasmid
pA7U-EAP1 which expresses full-length Eap1p under the con-
trol of strong ADH1 promoter. The wild-type and eap1D cells
were co-transformed with the p180k reporter, a derivative of
p180 bearing G418r marker, and pA7U-EAP1 or its backbone
vector pA7U. These transformants were cultivated in the pres-
ence of rapamycin, and examined for b-galactosidase activity.
As expected, overexpression of EAP1 eﬃciently suppressed the
rapamycin-induced GCN4 translation in the wild-type cells
(Fig. 2). It also suppressed the enhancement of rapamycin-in-
duced GCN4 translation in eap1D cells (Fig. 2), excluding the
possibility of an unexpected side-eﬀect caused by the alteration
of EAP1 locus, which is adjacent to TOR2. Taken together, we
conclude that Eap1p attenuates rapamycin-induced GCN4
translation.
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Fig. 2. Eﬀects of EAP1 overexpression on translational derepression of GCN4. The W303H (EAP1) and WH4 (eap1D) cells bearing p180k, a G418r-
marked derivative of p180, were transformed with pA7U-EAP1, pA7U-eap1-Y109A, pA7U-eap1-Y109A/L114A or its backbone vector pA7U. Note
that the KanMX cassette in WH4 strain had been excised using the Cre-loxP site-speciﬁc recombination system so that G418 could be used for the
maintenance of p180k. These transformants were treated for 2 h with 20 mM 3AT or 200 ng/ml rapamycin and assayed for b-galactosidase activity.
R. Matsuo et al. / FEBS Letters 579 (2005) 2433–2438 24353.3. EAP1 speciﬁcally attenuates rapamycin-induced translation
of GCN4 mRNA
We next examined whether deletion of EAP1 aﬀects GCN4
translation induced by 3-aminotriazole (3AT), an inhibitor of
His3p to cause histidine starvation. Notably, the deletion
barely aﬀects the translation induced by 3AT, in contrast with
that by rapamycin (Fig. 1C). Similarly, overexpression ofA
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Fig. 3. Speciﬁcity of the eﬀect of EAP1 deletion. (A) The W303H (EAP1) and
shifted to SC-Ura containing 20 mM 3AT, 200 ng/ml rapamycin, 50 lg/ml 8
chlorpromazine (CPZ) for 2 h, or a carbon starvation medium containing 0.0
of control W303H cells was taken as 100%. (B) The W303H and WH4 cells
treated with 200 ng/ml rapamycin for 4 h and subjected to b-galactosidase aEAP1 failed to suppress 3AT-induced GCN4 translation
(Fig. 2).
These results prompted us to test various stimuli reported to
induce GCN4 translation, including adenine starvation, carbon
starvation, methylmethanesulfonate and chlorpromazine
[2,14]. Intriguingly, deletion of EAP1 failed to enhance the
GCN4 translation induced by any of these stimuli (Fig. 3A).300 400 500 600
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eap1∆
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erepression (%) 
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WH4 (eap1D) cells bearing p180 were grown to logarithmic phase and
-azaadenine (azA), 0.07% methylmethanesulfonate (MMS) or 250 lM
5% glucose for 6 h prior to b-galactosidase assay. Note that the activity
were transformed with p180, p227, pRS-FAS-lacZ or pYES3/CT/lacZ,
ssay. The results were indicated by fold-derepression in percentile.
Fig. 4. Eﬀects of EAP1 deletion on eIF2a phosphorylation and a
rapamycin-insensitive gcn2-S577A mutant. (A) The amounts of
eIF2a[pS51] (upper panel) and eIF2a (lower panel) were examined
by immunoblotting with an anti-phospho-eIF2a antibody and an anti-
eIF2a antibody, respectively, in W303H (EAP1) and WH4 (eap1D)
cells that were treated for 2 h with 20 mM 3AT or 200 ng/ml
rapamycin. (B) The GCN4-lacZ reporter activity was measured in
W303H (wild), WH4 (eap1D), WH2 (gcn2D), WH24 (gcn2D eap1D),
WH9 (gcn2-S577A), and WH94 (gcn2-S577A eap1D) cells treated for
4 h with 20 mM 3AT or 200 ng/ml rapamycin.
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amycin-induced translation, reinforcing the notion of its
involvement in the TOR signaling.
We also examined whether deletion of EAP1 aﬀects transla-
tion of genes other than GCN4. For this purpose, we trans-
formed the wild-type and eap1D cells with other reporter
constructs, namely p227, pRS-FAS1-lacZ and pYES3/CT/
lacZ. The p227 is a derivative of p180 lacking the uORFs.
The pRS-FAS1-lacZ is a centromeric plasmid bearing lacZ re-
porter driven by the promoter and 5 0-untranslated region of
FAS1, whereas the pYES3/CT/lacZ is a multicopy plasmid
bearing lacZ driven by GAL1 promoter. These transformants
were treated with rapamycin, and examined for b-galactosi-
dase activity. As shown in Fig. 3B, none of the three reporters
showed diﬀerential response to rapamycin between the wild-
type and eap1D cells. These results suggest that the eﬀect of
EAP1 deletion on translation is not general but rather speciﬁc
to GCN4 mRNA. More importantly, failure of p227 to re-
spond to EAP1 deletion underscores the importance of the
uORFs in the 5 0-leader region.
3.4. EAP1 functions downstream of GCN2 to attenuate GCN4
translation
The importance of the uORFs prompted us to test whether
the well-established mechanism for the translational derepres-
sion of GCN4 mRNA, which is triggered by the activation of
Gcn2p, is augmented by deletion of EAP1. For this purpose,
we employed an antibody that speciﬁcally recognizes eIF2a
phosphorylated at Ser-51 (eIF2a[pS51]) to examine its abun-
dance. We, however, failed to ﬁnd any apparent diﬀerence in
the levels of eIF2a[pS51] between the wild-type and eap1D
cells, both treated with rapamycin (Fig. 4A). It thus seems that
the removal of Eap1p neither activates Gcn2p nor suppresses
eIF2a[pS51] phosphatase(s). Nevertheless, eIF2a [pS51] is a
prerequisite for the enhancement, because deletion of EAP1
failed to enhance GCN4 translation in the absence of the sole
eIF2a kinase Gcn2p (Fig. 4B).
To clarify how Gcn2p is involved in the process, we next
examined the eﬀect of EAP1 deletion in the cells bearing
gcn2-S577A, which encodes for Gcn2p(S577A) incapable of
being activated by rapamycin [9,10]. As reported previously,
rapamycin failed to derepress GCN4 translation in gcn2-
S577A cells (Fig. 4B). However, to our interest, rapamycin
derepressed GCN4 translation in gcn2-S577A eap1D cells as
eﬀectively as in GCN2 eap1D cells (Fig. 4B). We also exam-
ined the cells bearing gcn2-S577E allele, which had been
demonstrated to display compromised rapamycin-induced
Gcn2p activation, to observe that deletion of EAP1 confers
rapamycin-responsiveness in GCN4 translation (data not
shown).
These results indicate that a prerequisite for the enhance-
ment of GCN4 translation by EAP1 deletion is the basal, but
not the rapamycin-induced, Gcn2p activity. Thus rapamycin
is likely required for the activation of Eap1p but not Gcn2p.
Accordingly, deletion of EAP1 fails to aﬀect the translation in-
duced by other stimuli which activate Gcn2p but not Eap1p
(Fig. 3).
3.5. Association with eIF4E is dispensable for Eap1p to
attenuate GCN4 translation
To understand how rapamycin-activated Eap1p functions,
we examined whether its association with eIF4E is requiredfor the attenuation of GCN4 translation. We introduced a
mutation into the canonical eIF4E-binding motif of Eap1p
to replace Tyr at position 109 with Ala, thereby producing
Eap1p(Y109A) (Fig. 5A). To rule out the eﬀect of potential
residual eIF4E-binding activity of Eap1p(Y109A), we gener-
ated another mutant Eap1p(Y109A/L114A), because L114A
substitution corresponds to L45A in human 4E-BP3 that had
been demonstrated to abolish its eIF4E-binding [15]. As ex-
pected, the far-western blot analysis indicated that both Eap1-
p(Y109A) and Eap1p(Y109A/L114A) totally fail to interact
with eIF4E in vitro (Fig. 5B). Mass spectrometric analysis of
the aﬃnity-puriﬁed complexes including tagged Eap1p and
Eap1p(Y109A) provided compelling and no evidence for
eIF4E binding, respectively, implying that Eap1p(Y109A) fails
to interact with eIF4E in vivo (data not shown).
We prepared eap1D cells bearing an episomal copy of EAP1,
eap1-Y109A or eap1-Y109A/L114A, each expressing the pro-
tein tagged with T7-epitope at its N-terminal end. Immunoblot
analysis using a T7-antibody showed that steady state levels of
these proteins are comparable, indicating that the mutations
do not aﬀect the stability of Eap1p (Fig. 5B). Intriguingly,
when overexpressed, both eap1-Y109A and eap1-Y109A/
L114A encoding Eap1p incapable of binding eIF4E suppressed
the rapamycin-induced GCN4 translation as eﬃciently as
EAP1 encoding the protein fully capable of binding eIF4E
(Fig. 2). Furthermore, the cells bearing eap1-Y109A or eap1-
Fig. 5. Eﬀects of mutations abolishing eIF4E-binding of Eap1p on
GCN4 translation. (A) Structure of Eap1p is schematically represented
with the eIF4E-binding motif aligned with those of yeast Caf20p,
eIF4Gs, and human 4E-BPs. The consensus sequence is also shown
(bold letters, conserved residues; underlined letters, the conserved
ﬂanking sequences shared by Eap1p and Caf20p; X, any residues; U,
for hydrophobic residues; italic letters, substituted Ala). (B) The panel
shows Ponceau red stain image of the blot. The middle panel shows an
immunoblot detection of T7-tagged Eap1p, Eap1p-Y109A and Eap1p-
Y109A/L114A expressed episomally in WH4 (eap1D) cells with an
anti-T7 antibody. The bottom panel shows the far-western blot or a
protein overlay binding assay with GST-eIF4E probe to examine the
interactions of Eap1p, Eap1p-Y109A and Eap1p-Y109A/L114A with
eIF4E. (C) The W303H, WH41 (eap1-Y109A), WH42 (eap1-Y109A/
L114A) and WH4 cells were examined for 3AT- and rapamycin-
induced GCN4 translation as described in Fig. 4B.
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ment of rapamycin-induced GCN4 translation (Fig. 5C).
These results indicate that eIF4E-binding is dispensable for
the attenuation of GCN4 translation, suggestive of a novel
mode of action for Eap1p.4. Discussion
We demonstrated that deletion and overexpression of EAP1
speciﬁcally enhances and suppresses rapamycin-induced trans-
lation of GCN4 mRNA, respectively (Figs. 1–3). It seems thatrapamycin, or TOR-inactivation, derepresses Eap1p, which
functions downstream of Gcn2p to attenuate GCN4 transla-
tion (Fig. 4). Since the attenuation depends on the four uORFs
in the 5 0-leader region of GCN4 mRNA (Fig. 3B), Eap1p likely
contributes to maintain the level of eIF2-GTP-methionyl
tRNA ternary complex, notably, via a novel mechanism inde-
pendent of eIF4E-binding (Fig. 5). Although Eap1p was re-
ported to have a separate function from its eIF4E-binding in
the maintenance of genetic stability [13], we excluded its
involvement by conﬁrming that deletion of EAP1 does not af-
fect the dosage of p180 plasmid and lacZ mRNA at all. More
recently, genetic and biochemical interactions were reported
between EAP1 and SCP160, an RNA-binding protein shown
to associate with a speciﬁc subsets of mRNAs [16]. However,
we assume the involvement of these interactions unlikely, be-
cause of their dependence on eIF4E-binding [16]. Further
experiments are necessary to decipher the underlying mecha-
nism, and our preliminary results indicate that the region span-
ning amino acid residues 88–226 is responsible for the
attenuation.
The other question raised by the present study would be the
biological role for Eap1p-mediated attenuation of GCN4
translation. The eﬀect of rapamycin, or TOR-inactivation, is
an apparent paradox: rapamycin activates Gcn2p to induce
GCN4 translation on one hand, but derepresses Eap1p to
attenuate the translation on the other hand. A plausible expla-
nation may be that Eap1p constitutes a negative feedback loop
to ﬁne-tune the cellular response to nutritional stress. To mild
starvation such as that for amino acids, GAAC pathway is
activated to stimulate amino acid biosynthesis utilizing avail-
able carbon and nitrogen sources. However, when starvation
becomes much severer to deplete raw materials for biosynthe-
sis, it is reasonable for the cells to cease GAAC and activate
autophagy instead. Indeed, nitrogen starvation was reported
to repress GCN4 translation even in the presence of eI-
F2a[pS51] or downstream of Gcn2p [17]. It is thus conceivable
that Eap1p, which seems to be more activated under severer
starvation (Fig. 1), plays a role in such repression, thereby con-
tributing to ﬁne-tuning of cellular responses to starvation.
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